Clinical Trial Update: Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the predictive value of bio-imaging and biomarkers for hypofractionated radiation therapy in inoperable early-stage non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Hospital, Ghent | Conditions: Inoperable Early Stage Non-small Cell Lung Cancer | Phase 2 | Status: TERMINATED